Please login to the form below

Not currently logged in
Email:
Password:

Daichii Sankyo

This page shows the latest Daichii Sankyo news and features for those working in and with pharma, biotech and healthcare.

Astellas, Daiichi Sankyo and Takeda to study biomarkers

Astellas, Daiichi Sankyo and Takeda to study biomarkers

Astellas, Daiichi Sankyo and Takeda to study biomarkers. Collaboration aims to establish comprehensive database to accelerate drug development. ... Japanese pharmaceutical firms Astellas, Daiichi Sankyo and Takeda have joined forces to create a

Latest news

  • AZ and Daiichi Sankyo sign Movantik marketing deal AZ and Daiichi Sankyo sign Movantik marketing deal

    AZ and Daiichi Sankyo sign Movantik marketing deal. Two firms have agreed the deal for the new constipation pill. ... AstraZeneca has announced a new co-commercialisation agreement with Daiichi Sankyo for the constipation drug Movantik (naloxegol) in the

  • Thin on the ground

    Daichii Sankyo is developing edoxaban tosylate, which is also an orally active direct factor Xa inhibitor.

  • News in brief, June 20, 2007

    Its clients include US and EU pharmaceutical and biotechnology corporations including Allergan, Biogen Idec, Bristol-Myers Squibb, sanofi-aventis and Daichii Sankyo.

More from news
Approximately 2 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
wethepeople

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics